Cargando…

Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Cracowski, Jean-Luc, Molimard, Mathieu, Richard, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836747/ https://www.ncbi.nlm.nih.gov/pubmed/32553502 http://dx.doi.org/10.1016/j.therap.2020.06.002

Ejemplares similares

COVID-19: Pharmacology has kept the science ship running during the storm
por: Molimard, Mathieu, et al.
Publicado: (2021)

Benefit-risk balance of COVID drugs. New prospects
por: Cracowski, Jean-Luc, et al.
Publicado: (2022)

DPP-4 inhibitors and severe course of illness in patients with COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2021)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Drugs acting on renin angiotensin system and use in ill patients with COVID-19
por: Alexandre, Joachim, et al.
Publicado: (2020)

Diabetes and COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020)

French Spine Surgery Society guidelines for management of spinal surgeries during COVID-19 pandemic
por: Prost, Solène, et al.
Publicado: (2020)

Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
por: Grange, Lucile, et al.
Publicado: (2020)

American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre‐Conferences
por: Bai, Jane P.F., et al.
Publicado: (2019)

Diabète et COVID-19
por: Bouhanick, Béatrice, et al.
Publicado: (2020)

Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT)
por: Lemaitre, Florian, et al.
Publicado: (2022)

The Brazilian Society of Nephrology and the Covid-19 Pandemic
por: de Abreu, Andrea Pio, et al.
Publicado: (2020)

British Sleep Society: the COVID-19 pandemic response
por: Steier, Joerg, et al.
Publicado: (2020)

Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey
por: Khouri, Charles, et al.
Publicado: (2022)

Safety pharmacology during the COVID pandemic
por: Pugsley, Michael K., et al.
Publicado: (2021)

French Teledermatologists: Activity and Motivations Prior to the COVID-19 Pandemic
por: BATAILLE, Mathieu, et al.
Publicado: (2021)

Adverse event reporting and Bell's palsy risk after COVID-19 vaccination
por: Khouri, Charles, et al.
Publicado: (2021)

Indian Pharmacological Society: A SWOT analysis
por: Dhawan, B. N.
Publicado: (2011)

Pharmacology and Therapeutics in 1888
Publicado: (1889)

Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF)
por: Schnell, David, et al.
Publicado: (2016)

Critical care journals during the COVID-19 pandemic: challenges and responsibilities
por: Citerio, Giuseppe, et al.
Publicado: (2020)

COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL)
por: Leboulanger, N., et al.
Publicado: (2020)

COVID-19 and schools. Guidelines of the French Pediatric Society()
por: Cohen, R., et al.
Publicado: (2020)

Guidelines of the French Society of Otorhinolaryngology (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemic
por: Bertholon, P., et al.
Publicado: (2021)

All India Ophthalmological Society: Stance on COVID-19 pandemic
por: Sharma, Namrata, et al.
Publicado: (2020)

Did our pharmacological strategy for COVID‐19 fail?
por: Martin, Jennifer H., et al.
Publicado: (2021)

French society and the Revolution /
Publicado: (1976)

Understanding the variability of pharmaco‐epidemiological studies assessing the risk of appendicitis with mRNA COVID‐19 vaccines
por: Jambon‐Barbara, Clement, et al.
Publicado: (2022)

Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction
por: Girerd, Nicolas, et al.
Publicado: (2022)

Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients
por: Molimard, Chloé, et al.
Publicado: (2021)

ECMO during the COVID-19 pandemic: when is it unjustified?
por: Abrams, Darryl, et al.
Publicado: (2020)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Home hemodialysis during the COVID-19 epidemic: comment on the French experience from the viewpoint of a French home hemodialysis care network
por: Michel, Pierre-Antoine, et al.
Publicado: (2020)

Alliance between the International Union of Basic and Clinical Pharmacology and the Indian Pharmacological Society for Health, Education, Drug Discovery, and Development in India
por: Spedding, Michael, et al.
Publicado: (2016)

Materia Medica, or Pharmacology and Therapeutics
por: Tully, William
Publicado: (1853)

Shortage of sedatives and neuromuscular blockers during COVID-19 pandemic: The result of an overstocking procedure in French hospitals?
por: Montmeat, Déborah, et al.
Publicado: (2020)

Special issue—Sharing of best practices in response to the COVID-19 pandemic
por: Black, Richard A.
Publicado: (2022)

Pharmacologic Treatment of Obesity
por: Halpern, Alfredo, et al.
Publicado: (2011)

French Teeth
Publicado: (1857)

The French Congress
Publicado: (1889)

Cannot write session to /tmp/vufind_sessions/sess_s3f7f2al20lfv6h8ag983hlnbl